Because CMS considers diabetes medication adherence to be a critical component of its medication-related quality measures, as evidenced in its Part C and D Star Ratings (D10-Medication Adherence for Diabetes Medications),111 it only makes sense that individuals treated with intensive insulin therapy have the option to choose the insulin delivery method that meets their individual needs and preferences. Here, INS is linked to diabetes mellitus.